112 related articles for article (PubMed ID: 36756481)
1. Association of Mortality with Lymphocyte Subset in Patients with COVID-19-associated Acute Respiratory Failure: A Subgroup Analysis.
Vadi S; Pednekar A; Suthar D; Sanwalka N; Rabade N; Ghodke K
Indian J Crit Care Med; 2023 Jan; 27(1):52-56. PubMed ID: 36756481
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and Predictive Value of T-lymphocyte Subset Absolute Counts in Patients with COVID-19-associated Acute Respiratory Failure: A Retrospective Study.
Vadi S; Pednekar A; Suthar D; Sanwalka N; Ghodke K; Rabade N
Indian J Crit Care Med; 2022 Nov; 26(11):1198-1203. PubMed ID: 36873590
[TBL] [Abstract][Full Text] [Related]
3. In Response to Author: COVID-19 and T Cells: Do T Cells Really Matter?
Vadi S; Pednekar A; Suthar D; Sanwalka N; Ghodke K; Rabade N
Indian J Crit Care Med; 2023 Jan; 27(1):76. PubMed ID: 36756483
[No Abstract] [Full Text] [Related]
4. Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study.
Iannetta M; Buccisano F; Fraboni D; Malagnino V; Campogiani L; Teti E; Spalliera I; Rossi B; Di Lorenzo A; Palmieri R; Crea A; Zordan M; Vitale P; Voso MT; Andreoni M; Sarmati L
Sci Rep; 2021 Jun; 11(1):12762. PubMed ID: 34140530
[TBL] [Abstract][Full Text] [Related]
5. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
[TBL] [Abstract][Full Text] [Related]
6. Poor Survival in COVID-19 Associated with Lymphopenia and Higher Neutrophile-Lymphocyte Ratio.
Montiel-Cervantes LA; Medina G; Pilar Cruz-Domínguez M; Pérez-Tapia SM; Jiménez-Martínez MC; Arrieta-Oliva HI; Carballo-Uicab G; López-Pelcastre L; Camacho-Sandoval R
Isr Med Assoc J; 2021 Mar; 23(3):153-159. PubMed ID: 33734627
[TBL] [Abstract][Full Text] [Related]
7. Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.
Xu B; Fan CY; Wang AL; Zou YL; Yu YH; He C; Xia WG; Zhang JX; Miao Q
J Infect; 2020 Jul; 81(1):e51-e60. PubMed ID: 32315725
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of lymphocyte subsets and cytokine profiles of patients with COVID-19.
Pan P; Du X; Zhou Q; Cui Y; Deng X; Liu C; Hu Z; Chen J; Yu X; Shi W
Virol J; 2022 Mar; 19(1):57. PubMed ID: 35346253
[TBL] [Abstract][Full Text] [Related]
9. [Difference and significance of T-lymphocyte subsets in differential diagnosis between severe acute respiratory syndrome and common atypical pneumonia].
Li MH; Li XH; Li XW; Ma L; Yi W; Jiang YY; Dong JP; Li WL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Jun; 18(2):137-41. PubMed ID: 15340501
[TBL] [Abstract][Full Text] [Related]
10. Inflammation as Prognostic Hallmark of Clinical Outcome in Patients with SARS-CoV-2 Infection.
Fuzio D; Inchingolo AM; Ruggieri V; Fasano M; Federico M; Mandorino M; Dirienzo L; Scacco S; Rizzello A; Delvecchio M; Parise M; Rana R; Faccilongo N; Rapone B; Inchingolo F; Mancini A; Fatone MC; Gnoni A; Dipalma G; Dirienzo G
Life (Basel); 2023 Jan; 13(2):. PubMed ID: 36836679
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of lymphocyte count, T-cell subsets and neutrophil-to-lymphocyte ratio as early predictors for severity and outcome of COVID-19 disease-a report from a highly complex hospital in Brazil.
Oliveira DC; Spiri BS; Schluga YC; Justus JLP; Lopes Neto FDN; Azambuja AP
Hematol Transfus Cell Ther; 2023; 45(3):330-337. PubMed ID: 35782909
[TBL] [Abstract][Full Text] [Related]
12. Serum LD1 isoenzyme and blood lymphocyte subsets as prognostic indicators for severe acute respiratory syndrome.
Chan MH; Wong VW; Wong CK; Chan PK; Chu CM; Hui DS; Suen MW; Sung JJ; Chung SS; Lam CW
J Intern Med; 2004 Apr; 255(4):512-8. PubMed ID: 15049886
[TBL] [Abstract][Full Text] [Related]
13. Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19.
Fu HY; Luo Y; Gao JP; Wang L; Li HJ; Li X; Xue L; Tang XQ; Li HW; Du YR
Biomed Res Int; 2020; 2020():2854186. PubMed ID: 33015160
[TBL] [Abstract][Full Text] [Related]
14. TREC/KREC Levels and T and B Lymphocyte Subpopulations in COVID-19 Patients at Different Stages of the Disease.
Savchenko AA; Tikhonova E; Kudryavtsev I; Kudlay D; Korsunsky I; Beleniuk V; Borisov A
Viruses; 2022 Mar; 14(3):. PubMed ID: 35337053
[TBL] [Abstract][Full Text] [Related]
15. Validation of the T-Lymphocyte Subset Index (TLSI) as a Score to Predict Mortality in Unvaccinated Hospitalized COVID-19 Patients.
Di Lorenzo A; Tedde S; Pace PG; Campogiani L; Ansaldo L; Lodi A; Zordan M; Barreca F; Caldara F; Rossi B; Imeneo A; Alessio G; Crea AMA; Checchi D; Malagnino V; Teti E; Coppola L; Palmieri R; Buccisano F; Andreoni M; Sarmati L; Iannetta M
Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359306
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study.
Zhang J; Wang Z; Wang X; Hu Z; Yang C; Lei P
Front Immunol; 2021; 12():581469. PubMed ID: 33664741
[No Abstract] [Full Text] [Related]
17. Abnormal immunity of non-survivors with COVID-19: predictors for mortality.
Zhao Y; Nie HX; Hu K; Wu XJ; Zhang YT; Wang MM; Wang T; Zheng ZS; Li XC; Zeng SL
Infect Dis Poverty; 2020 Aug; 9(1):108. PubMed ID: 32746940
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19.
Kazancioglu S; Yilmaz FM; Bastug A; Sakallı A; Ozbay BO; Buyuktarakci C; Bodur H; Yilmaz G
Viral Immunol; 2021 Jun; 34(5):342-351. PubMed ID: 33264073
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients.
Zhang P; Du W; Yang T; Zhao L; Xiong R; Li Y; Geng Y; Lu W; Zhou J
Int J Immunopathol Pharmacol; 2021; 35():20587384211048567. PubMed ID: 34619994
[TBL] [Abstract][Full Text] [Related]
20. T cell counts and IL-6 concentration in blood of North African COVID-19 patients are two independent prognostic factors for severe disease and death.
Belaid B; Lamara Mahammad L; Mihi B; Rahali SY; Djidjeli A; Larab Z; Berkani L; Berkane I; Sayah W; Merah F; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Ayoub S; Hamidi RM; Derrar F; Gharnaout M; Allam I; Djidjik R
J Leukoc Biol; 2022 Jan; 111(1):269-281. PubMed ID: 33527487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
